Identification of activated T cells that might have contacted tumors characterized by circulating neoantigen-specific granzyme B+ PD-1+ T cells in melanoma [82] and a similar pool in lung cancer albeit antigen-specificity was not assessed in this case [62]. This evidence concerns the gene GZMB and melanoma.